Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding protein MEX3B is encoded by the MEX3B gene and functions as a post-transcriptional regulator modulating the stability and translation of specific mRNAs. It features two K homology (KH) RNA-binding domains and a RING finger domain, enabling it to bind RNA and participate in protein-protein interactions. MEX3B controls the expression of target mRNAs, including its own by an autoregulatory loop, and those involved in developmental signaling (e.g., FGF pathway), immune responses (as a TLR3 coreceptor), and immune evasion in cancer by destabilizing HLA-A mRNA. Dysregulation of MEX3B impacts neural development and cancer immunotherapy efficacy[1][2][5][7].
For agents modulating MEX3B activity (experimental/biological), expected mechanisms would involve modification of MEX3B’s mRNA binding, destabilization of target mRNAs (such as HLA-A, TGFBR3), or altering its regulatory loops[1][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding protein MEX3B (MEX3B).